• Newron announces improved motor function in phase III Parkinson's trial of Safinamade

    3 February 2009
    Download

  • Biomarin's Kuvan receives marketing approval in the EU

    9 December 2008
    Download

  • Broncus Technologies Secures 38$ Million in fundind round led by Ares Life Sciences

    4 December 2008
    Download

  • Sale of private portfolio company Panomics

    12 November 2008
    Download

  • Biovitrum extends ReFacto supply agreement with Wyeth until Dec. 31, 2015

    12 November 2008
    Download

  • Brahms announces new blood test better predicts heart failure outcomes in emergency setting

    11 November 2008
    Download

  • Paratek reports positive phase 2 clinical data on antibiotic PTK 0796

    26 October 2008
    Download

  • Mpex Pharmaceuticals presents new data on MP-376 in Cystic Fibrosis

    23 October 2008
    Download

  • Probiodrug's new Alzheimer's treatment paradigm published in Nature Medicine

    28 September 2008
    Download

  • Takeover of public portfolio company CryoCath Technologies

    26 September 2008
    Download

  • Biovitrum to acquire Kepivance, Stemgen and exclusively license

    15 September 2008
    Download

  • Basilea's Toctino (alitretinoin) receives first national marketing authorization in the UK

    8 September 2008
    Download

  • BRAHMS AG: Substantial success in the improvement of diagnosis of patients suffering from shortness of breath

    1 September 2008
    Download

  • Anthera Pharmaceuticals initiates FRANCIS in patients with acute coronary syndrome

    25 August 2008
    Download

  • Pelikan Technologies and Lilly form alliance to promote diabetes education

    16 August 2008
    Download

  • Anthera Pharmaceuticals completes $19 million financing

    13 August 2008
    Download

  • ESBATech raises additional CHF 23M (USD 22M), extending Series B Venture Financing

    7 August 2008
    Download

  • Onyx' Nexavar approved for liver cancer in China

    28 July 2008
    Download

  • PTC Therapeutics closes significant cooperation agreement with Genzyme, receives $ 100 million upfront payment

    17 July 2008
    Download

  • FDA grants conditional approval to Interventional Spine's PercuDyn system IDE application

    1 July 2008
    Download

  • Basilea's Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada

    30 June 2008
    Download

  • Ipsen to acquire Tercica

    4 June 2008
    Download

  • PharmaSwiss raises EUR 35 million from private equity fund

    20 May 2008
    Download

  • Onyx' Nexavar significantly improves overall survival by 47% in Asia-Pacific liver cancer study

    16 May 2008
    Download

  • Paratek Pharmaceuticals completes $40 Million private placement to finance clinical programs including oral anti-MRSA antibiotics

    16 April 2008
    Download
    • More news